A leading pharma manufacturer partnered with Mu Sigma to optimize promotional spending across various channels and geographies. The goal was to maximize profits in the NOAC (Novel Oral Anticoagulants) and DME (Diabetic Macular Edema) markets.

Specialty

Pharma

Solution Category

Marketing Mix Modeling

We implemented a 2-step Marketing Mix Modeling (MMx) methodology that:

Significantly improved data analysis readiness through the application of data transformation methods, including Linear-Linear, Log-Log, Linear-Log, Time Trend Variable, Dummy Variable, and Interaction Variable.

Strengthened outcome assessment utilizing diverse modeling techniques, such as Multivariate Additive Regression Splines (MARS), Ordinary Least Squares (OLS), and Partial Least Squares (PLS).

Promoted independent execution of MMx projects by the local teams through reusable components such as Jupyter notebooks.

The modeling exercise helped determine the relative impact of personal and non-personal promotions on drug prescription volumes in various regions. It also revealed that digital channels consistently delivered a higher ROI, emphasizing the need for action. Additionally, it identified non-responsive geographic areas, prompting the revision of promotional strategies and budget allocation in those regions.

Business Impact

  • $14 Million

    Profit Increase, Spanning 5 regions and 2 brands

  • Globally Scaled

    MMx models in 30 markets across 18 geographies

Mu Sigma is a pure-play decision sciences company that believes the big D is Decisions, not data. Our integrated ecosystem of products, services and cross-industry best practices, Mu Sigma enables better decision-making for more than 140 Fortune 500 clients. Mu Sigma's unique interdisciplinary approach and application of AI, ML, computer vision and more drive innovation in solving high-impact business problems across sales, marketing, finance, operations, and supply chain. With over 3,800 decision scientists and experience across 12 industry verticals, Mu Sigma has been consistently validated as the preferred Decision Sciences and Analytics partner.